Literature DB >> 16580832

Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps.

S Shahana1, Z Jaunmuktane, M Stenkvist Asplund, G M Roomans.   

Abstract

Nasal polyposis is a poorly understood chronic inflammatory disease often associated with asthma. As nasal polyps and asthma both are associated with massive eosinophil infiltration, they may share a common pathophysiological mechanism. Many genetic and autoimmune diseases may result from altered expression or function of cell adhesion molecules such as desmosomes. A transmission electron microscopical study was carried out on tissue from 15 patients suffering from nasal polyps, to investigate if there are changes in desmosomes in nasal polyps from asthmatic and/or allergic patients versus non-asthmatic versus non-allergic patients. In allergic patients the damage to columnar cells was more extensive than in non-allergic patients. Massive infiltration of eosinophils was observed in epithelium and connective tissue in all groups. No significant difference in thickness of the basal lamina was found between any of the groups. All patients had dilated capillaries in the connective tissue. The intercellular space between the epithelial cells was smallest in the asthmatic non-allergic group. The relative length of columnar cell or basal cell desmosomes was reduced in patients with asthma or allergy, compared to non-allergic, non-asthmatic patients. Hence, there appears to be a weakness in the desmosomes in asthmatics and allergics. Epithelial shedding may play an important role in the pathophysiological process of a multifactorial disease such as asthma.

Entities:  

Mesh:

Year:  2006        PMID: 16580832     DOI: 10.1016/j.rmed.2006.02.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

1.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

Authors:  Ricard Farré; Rita De Vos; Karel Geboes; Kristine Verbecke; Pieter Vanden Berghe; Inge Depoortere; Kathleen Blondeau; Jan Tack; Daniel Sifrim
Journal:  Gut       Date:  2007-02-01       Impact factor: 23.059

Review 2.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

3.  Wnt Signaling in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Robert Böscke; Eszter K Vladar; Michael Könnecke; Birgit Hüsing; Robert Linke; Ralph Pries; Norbert Reiling; Jeffrey D Axelrod; Jayakar V Nayak; Barbara Wollenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

Review 4.  Mechanisms and pathogenesis of chronic rhinosinusitis.

Authors:  Atsushi Kato; Robert P Schleimer; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-03-01       Impact factor: 14.290

5.  Epithelial genes in chronic rhinosinusitis with and without nasal polyps.

Authors:  Sara L Richer; Ai Q Truong-Tran; David B Conley; Roderick Carter; David Vermylen; Leslie C Grammer; Anju T Peters; Rakesh K Chandra; Kathleen E Harris; Robert C Kern; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008 May-Jun

Review 6.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

7.  The Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis.

Authors:  L F Keglowich; P Borger
Journal:  Open Respir Med J       Date:  2015-06-17

8.  Perip7lakin is a target for autoimmunity in asthma.

Authors:  Camille Taillé; Sabine Grootenboer-Mignot; Candice Estellat; Carine Roy; Sophie Ly Ka So; Marina Pretolani; Michel Aubier; Bruno Crestani; Sylvie Chollet-Martin
Journal:  Respir Res       Date:  2016-10-07

9.  EGF Protects Epithelial Cells from Barrier Damage in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Le Chen; Quan Liu; Zhuofu Liu; Han Li; Xiang Liu; Hongmeng Yu
Journal:  J Inflamm Res       Date:  2022-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.